At AAIC 2022, Translucence Presented Their Work on Brain-Wide Measurement of Antibody Therapeutics, Microglia and β-Amyloid Plaques

by
Translucence Biosystems
August 3, 2022

Translucence Co-Founders Damian Wheeler, Ph.D. and Sunil Gandhi, Ph.D. along with their colleagues Chase Redd and Nathaniel Guanzon recently presented at the Alzheimer's Association International Conference® 2022. To help move AD drug discovery forward, Translucence has developed whole-brain regional assays for β-Amyloid plaques and microglia and with Lundbeck, methods to measure antibody therapeutics crossing the Blood-Brain Barrier and homing in on their target.

Access the "Brain Wide Monitoring of Antibody Therapeutics Crossing the Blood/Brain Barrier" poster here.

Access the "Brain-Wide Cellular Resolution Regional Quantification of Microglia and Amyloid in 5xfad Mice" poster here.

Download materials

Download materials

To access materials from this article, please complete the corresponding form

Mesoscale Imaging System™
Manual

Thank you, for trusting Translucence Biosystems as a partner in your research journey!
No items found.
Something went wrong while submitting the form.
Please, contact us info@translucencebio.com

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

December 2, 2025
Updates

Translucence Biosystems Attends 2025 Society for Neuroscience Annual Meeting

Translucence Biosystems participated in the Society for Neuroscience annual meeting, held November 15–19, 2025, in San Diego, California. The team hosted booth #3224, where they connected with the neuroscience community and discussed how tissue clearing can help accelerate neuroscience research. The team also presented five posters showcasing advancements in high-resolution whole-brain clearing, imaging, and analysis. Together, these posters highlighted tools and techniques that address the limitations of traditional histology, including tissue clearing, light sheet imaging, AI-powered 3D quantification, and cloud-based platforms that enable comprehensive whole-brain and organ-level insights at scale. See an outline of the posters presented below!
by
Nathaniel Guanzon
August 13, 2025
Updates

AAIC25 Highlights: Translucence Biosystems Showcases Tools for 3D Whole-Brain Quantification of Alzheimer’s Pathology and Therapeutic Distribution

Translucence Biosystems recently participated in the Alzheimer's Association International Conference® (AAIC25), where CEO Damian Wheeler presented two posters demonstrating Translucence's whole-brain 3D tissue clearing techniques and AI-powered quantification pipeline. These presentations highlighted next-generation methodologies for quantifying disease burden and mapping therapeutic biodistribution at cellular resolution across the entire brain.
by
Angela Prvulovic
May 12, 2025
Updates

Translucence Biosystems hosts Lunch and Learn Event in Partnership with the UC Berkeley Molecular Imaging Core

Translucence Biosystems hosted an informative Lunch and Learn event in collaboration with the Molecular Imaging Center at the UC Berkeley Cancer Research Lab on Wednesday, April 9th, 2025.
by
Angela Prvulovic